BIO-RAD LABORATORIES, INC. (BIO) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was $384 M, a 457% increase year-over-year.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$322 M, a 68.6% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$637 M, a 82.4% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.63 B, a 185% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $4.25 B, a 11.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$322 M $384 M +$315 M +457% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$637 M $350 M -$478 M -57.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 -$159 M $106 M +$269 M Jul 1, 2023 Sep 30, 2023 10-K 2024-02-16
Q2 2023 -$428 M -$1.16 B -$237 M -25.6% Apr 1, 2023 Jun 30, 2023 10-K 2024-02-16
Q1 2023 -$191 M $69 M +$3.44 B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$3.63 B $828 M +$2.4 B Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 -$6.03 B -$163 M -$4.09 B -104% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-16
Q2 2022 -$1.94 B -$925 M -$1.84 B -201% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-16
Q1 2022 -$93.1 M -$3.37 B -$4.35 B -444% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-16
Q4 2021 $4.25 B -$1.57 B -$2.41 B -287% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-17
Q3 2021 $6.67 B $3.93 B +$2.61 B +199% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-17
Q2 2021 $4.05 B $917 M -$49.6 M -5.13% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-17
Q1 2021 $4.1 B $980 M +$294 M +42.9% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-17
Q4 2020 $3.81 B $839 M +$286 M +51.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-11
Q3 2020 $3.52 B $1.31 B +$1.57 B Jul 1, 2020 Sep 30, 2020 10-K 2022-02-11
Q2 2020 $1.95 B $966 M +$368 M +61.4% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-11
Q1 2020 $1.58 B $686 M -$179 M -20.7% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-11
Q4 2019 $1.76 B $554 M +$1.38 B Oct 1, 2019 Dec 31, 2019 10-K 2021-02-16
Q3 2019 $377 M -$259 M -$528 M -196% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-16
Q2 2019 $905 M $599 M +$331 M +123% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-16
Q1 2019 $574 M $865 M +$208 M +31.7% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-16
Q4 2018 $366 M -$829 M -$911 M -1102% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $1.28 B $269 M +$247 M +1119% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 $1.03 B $268 M +$263 M +5260% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 $767 M $657 M +$644 M +5197% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $122 M $82.7 M +$101 M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $20.8 M $22.1 M +$5 M +29.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-04-01
Q2 2017 $15.8 M $5 M -$11.6 M -69.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-04-01
Q1 2017 $27.4 M $12.4 M +$1.4 M +12.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-04-01
Q4 2016 $26 M -$18.7 M -$68.2 M -138% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $94.2 M $17.1 M -$300 K -1.72% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $94.5 M $16.6 M -$11.8 M -41.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $106 M $11 M -$6.8 M -38.2% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $113 M $49.5 M +$10.5 M +26.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $103 M $17.4 M +$5.9 M +51.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $96.7 M $28.4 M -$3.2 M -10.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 $99.9 M $17.8 M +$11.1 M +166% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 $88.8 M $39 M +$8.9 M +29.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $79.9 M $11.5 M +$18.6 M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $61.3 M $31.6 M -$3 M -8.67% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $64.3 M $6.7 M -$13.5 M -66.8% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $77.8 M $30.1 M -$11.9 M -28.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 $89.7 M -$7.1 M -$49.7 M -117% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 $139 M $34.6 M -$13.7 M -28.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 $153 M $20.2 M -$10.8 M -34.8% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 $164 M $42 M -$17.2 M -29.1% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-18
Q3 2012 $181 M $42.6 M -$3.27 M -7.12% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $184 M $48.3 M +$8.34 M +20.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $176 M $31 M -$2 M -6.05% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $178 M $59.2 M -$8.7 M -12.8% Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $187 M $45.9 M +$1.1 M +2.46% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $186 M $40 M +$2 M +5.26% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $184 M $33 M -$1.9 M -5.44% Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q4 2010 $186 M $67.9 M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $44.8 M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $38 M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $34.9 M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.